23andMe’s COVID-19 study

The major goal of 23andMe’s COVID-19 study is to uncover genetic risks associated with severe outcomes of infections by SARS-CoV-2. Such associations may explain some variation in COVID-19 disease severity. In addition to providing direct-to-consumer genetic testing through the 23andMe® Service, 23andMe endeavors to advance biomedical science through genetic research.

What is the rationale for the 23andMe COVID-19 study?

Our primary objective is to investigate genetic links that could predispose individuals to severe COVID-19 symptoms. 23andMe’s large research database containing millions of genotyped individuals, combined with our ability to quickly survey our research participants, means that we are well placed to address questions related to the genetics of COVID-19 outcomes. If we are able to identify genetic links with COVID-19 outcomes, it may ultimately help researchers and scientists better understand the biology of the disease and why some experience more severe symptoms than others.

Moar

https://research.23andme.com/covid19/?fbclid=IwAR3geKTGIN6ReUoZKUwXHSKIQSTmoxUEiKPKFhSlT38czbj9-Ge-K0KT_TY